Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 4Phase NA 2Phase 1/2 2Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Leukemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Extranodal NK-T-Cell 2Leukemia, Biphenotypic, Acute 1

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 5Etoposide 5Cyclosporine 4Mycophenolic Acid 3Methotrexate 3Melphalan 3Cyclophosphamide 3Antilymphocyte Serum 3pegaspargase 2Methylprednisolone 2Cytarabine 2Carmustine 2Busulfan 2thymoglobulin 1plerixafor 1denileukin diftitox 1Vincristine 1Thiotepa 1Salvia hispanica seed extract 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Positron-Emission Tomography 1Oxycodone 1Ondansetron 1O(6)-benzylguanine 1Morphine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Extranodal NK-T-Cell × pegaspargase × Clear all
NCT06069830 2026-01-27

ENKTL

Ruijin Hospital

Phase NA Recruiting
89 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT02733458 2021-09-14

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Completed
52 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡